CrossrefInfokarte
Innovations in HER2-targeted therapy: A comprehensive review of trastuzumab deruxtecan
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · 2026-04 · 1881 (2) · 189550
DOI: 10.1016/j.bbcan.2026.189550 ↗Abstract
Kein Abstract verfügbar.
EUVIMED